Cognitive function in ecstasy naïve abstinent drug dependants and MDMA users

Current Drug Abuse Reviews

Volumn 6, Issue 1, 2013, Pages 71-76

  Potter, Adam ^a   Downey, Luke ^a   Stough, Con ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

CDR; Cognition; Ecstasy; MDMA; Polydrug; Working memory

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MENTAL TASK; PRIORITY JOURNAL; PROFILE OF MOOD STATES; TASK PERFORMANCE; WORKING MEMORY;

ADULT; AFFECT; CASE-CONTROL STUDIES; COGNITION; DEPRESSION; DRUG USERS; FEMALE; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 84880152866     PISSN: 18744737     EISSN: 18744745     Source Type: Journal    
DOI: 10.2174/1874473711306010008     Document Type: Article

References (30)

1. Degenhardt L, Barker B, Topp L: Patterns of ecstasy use in Australia: findings from a national household survey. Addiction 2004; 99.
2. Degenhardt L, Coffey C, Carlin JB, Moran P, Patton G: Who are the new amphetamine users? A 10-year prospective study of young Australians. Addiction 2007; 102.
3. Rogers RD, Robbins TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol. 2001 Apr;11(2): 250-7.
4. Yücel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, Lubman DI: Regional brain abnormalities associated with longterm heavy cannabis use. Arch Gen Psychiatry 2008: 65(6), 694-701.
5. Clemens KJ, McGregor IS, Hunt GE, Cornish JL: MDMA, metamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug Alcohol Rev 2007; 26.
6. Comer SD, Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW: Effects of repeated oral methamphetamine use in humans. Psychopharmacology 2001: 155, 397-404.
7. deWit H, Engasser JL, Richards JB: Acute administration of damphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 2002; 27, 813-825.
8. Magill RA, Waters WF, Bray GA, Volaufova J, Smith SR, Lieberman HR, McNevin N, Ryan DH: Effects of tyrosine, phentermine, caffeine, d-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nutri Neurosci 2003; 6(4), 237-246.
9. Butler GKL, Montgomery AMJ: Impulsivity, risk-taking and recreational ecstasy (MDMA) use. Drug Alcohol Depend 2004; 76.
10. Mills KC, Spruill SE, Kanne RW, Parkman KM, Zhang Y: The influence of stimulants, sedatives, and fatigue on tunnel vision: risk factors for driving and piloting. Hum Factors 2001; 43(2).
11. Fox HC, Parrott AC, Turner JJD: Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. J Psychopharm 2001; 15(4).
12. Croft RJ, Mackay AJ, Mills ATD, and Gruzelier JGH: Electrophysiological evidence of serotonergic impairment in longterm MDMA ('Ecstasy') users. Am J Psychiatry 2001; 158, 1687-1692.
13. Gouzoulis-Mayfrank E, Daumann J: Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage? Addiction 2006; 101 (3), 348-361.
14. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding YS, Pappas N: Association of methylphenidateinduced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: Implications in addiction. Am J Psychiatry 1999; 156:19-26.
15. Morgan MJ: Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 2000; 152, 230-248.
16. Morgan M, McFie L, Fleetwood L, Robinson J: Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence. Psychopharmacology 2002; 159, 294-303.
17. Karlsen SN, Spigset O, Slordal L: The Dark Side of Ecstasy: Neuropsychiatric Symptoms after Exposure to 3, 4 Methylenedioxymethamphetamine. Bas Clin Pharmacol Toxicol 2007; 102, 15-24.
18. McCardle K, Luebbers S, Carter J, Croft R,. Stough C: Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology 2004; 173, 434-439.
19. Beck AT, Steer RA, Ball R, Ranieri WF: Comparison of Beck Depression Inventories-IA and-II in Psychiatric Outpatient. J Pers Assess 1996; 588-597.
20. McNair D, Lorr M, Droppleman L: Manual: Profile of Mood States, 1971 San Diego, CA: Educational and Industrial Testing Service.
21. Wesnes KA, Ward T, Ayre G, Pincock C: Validity and utility of the Cognitive Drug Research (CDR) computerised assessment system: A review following fifteen years of usage. Eur Neuropsychopharmacol 1999; 9 (Suppl 5): S368.
22. Stough C, King R, Papafotiou K, Swann P, Ogden E, Wesnes K, Downey LA: The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning. Psychopharmacology 2011; 220(4), 799-807.
23. Bhattachary S, Powell JH: Recreational use of 3, 4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment. Psychol Med 2001; 31, 647-658.
24. Hasin DS, Nunes E, Meydan J: Comorbidity of alcohol, drug, and psychiatric disorders: epidemiology. In: Kranzler, Treatnent: Substance Abuse and Comorbid Disorders: 2004, 2nd edn, pp, 1-34, New York: Marcel Dekker.
25. Guillot C, Greenway D: Recreational Ecstasy Use and Depression Journal of Psychopharmacology 2006; 20, 411.
26. Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M: Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction J Psychopharmacol 2006; 20, 373-384.
27. Wareing M, Murphy P, Fisk, J: Visuospatial memory impairments in users of MDMA ('ecstasy'). Psychopharmacology 2004: 173, 391-397.
28. Back-Madruga C, Boone K, Chang L, Grub C, Lee A, Nations H, Poland R: Neuropsychological effects of 3, 4-methylenedioxymethampheta -mine (MDMA or Ecstasy) in recreational users. The Clin Neuropsych 2003; 17, 446-459.
29. Heffernan T, Jarvis H, Rodgers J, Scholey A, Ling J: Prospective memory, everyday cognitive failure and central executive function in recreational users of ecstasy. Hum Psychopharmacol Clin Exo 2001; 16, 607-612.
30. McCann U, Mertl M, Eligulashvili V, Ricaurte G: Cognitive performance in (±) 3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) users: a controlled study. Psychopharmacology 1999; 143, 417-425.